Navigation Links
Australian Patent Office Grants Patent Covering RoosterBio’s Novel Compositions and Formulations for Ready-to-Print (RTP) Cells
Date:9/30/2019

RoosterBio Inc, a biotechnology market disrupter and leading supplier of innovative human mesenchymal stem/stromal cell (hMSC) biomanufacturing systems, today announced it has received patent approval in Australia for novel product formulations related to “Ready-to-Print” (RTP) cellular product formats (patent number AU 2015259373). This new patent adds intellectual property (IP) protection, including methods, uses and compositions in Australia. The RoosterRTP™ patent application has also been filed in the United States, Europe, South Korea, Japan, Canada, Israel and China.

“This is a significant and exciting decision for RoosterBio because this patent represents foundational technology related to biopreserved formulations of cells for tissue engineering and bioprinting applications,” said Jon A. Rowley, PhD, RoosterBio’s Founder and Chief Product Officer. “Issuance of this patent strengthens our leading intellectual property portfolio and further validates RoosterBio’s novel technology platform for accelerating regenerative medicine.”

Bioprinting of living cells and tissues creates unique product requirements related to shelf life and printability of living cells. RoosterBio was the first to launch a “ready-to-print” product formulation, RoosterRTP™, allowing bioprinters and tissue engineers to thaw and use large quantities of hMSCs for same day experiments, avoiding time-, labor- and cost-intensive cell expansion processes. “The most significant challenge in the advancement of 3D bioprinting has been the scarce availability of living cellular biomaterials for printing. Until RoosterBio, generating hMSCs would take a significant amount of time to culture and expand cells for the bioprinting process. With RoosterRTP™, we’re radically simplifying the most complex and labor-intensive aspects of bioprinting, saving users weeks of culture time and driving down the cost of cellular bioprinting.” Dr. Rowley added, “Our vision is a world where safe and effective regenerative medicines are rapidly developed and are widely available on a global scale, to benefit the lives of patients in need.”

RoosterRTP™ has been used by multiple customers, including the U.S. Military, to bring next-generation critical wound care closer to forward-deployed military positions.

For more information about RoosterRTP™, please visit https://www.roosterbio.com/collections/high-volume-hmscs.

About RoosterBio, Inc
RoosterBio, Inc. is a privately held cell manufacturing platform technology company focused on accelerating the development of a sustainable regenerative medicine industry, one customer at a time. RoosterBio's products are high-volume, affordable, and well-characterized adult human mesenchymal stem/stromal cells (hMSCs) paired with highly engineered media systems. RoosterBio has simplified and standardized how stem cells are purchased, expanded, and used in development, leading to marked time and costs savings for customers. RoosterBio's innovative products are ushering in a new era of productivity and standardization into the field, accelerating the road to discovery in Regenerative Medicine. For more information on RoosterBio, please visit http://www.roosterbio.com.

Read the full story at https://www.prweb.com/releases/australian_patent_office_grants_patent_covering_roosterbios_novel_compositions_and_formulations_for_ready_to_print_rtp_cells/prweb16612191.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Climate tug of war disrupting Australian atmospheric circulation patterns
2. Scientists find that dolphin in Australian waters is a new species
3. Australian marine reserves provide safe passageway for endangered species
4. Glycomics Institute to assist Australian sugar industry
5. Scientists name new species of cetacean: The Australian humpback dolphin
6. Nutrition an issue for Indigenous Australians
7. Stillbirth gap closing between indigenous and non-indigenous women, shows Australian study
8. Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan
9. Shared Medical Resources, LLC files suit against Histologics, LLC, Womens Health Laboratories and Avero Diagnostics for Willful Patent Infringement
10. Patent issued for beneficial animal candy
11. Patent awarded today to NJIT for novel use of water jets to create high tensile strength alloy parts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/14/2020)... ... February 14, 2020 , ... Trial By Fire Solutions, a ... Payment tracking, will be showcasing SimpleTrials at the Summit For Clinical Ops Executives ... Summit last year, the SimpleTrials team has completed full validation of the system ...
(Date:2/11/2020)... ... , ... Modality Solutions, a leading biopharmaceutical cold ... by certification body Intertek. Modality Solutions’ Quality Manager, Hannah Anderson, spearheaded the year-long ... Operating Procedures (SOPs) and created ten new SOPs. Anderson trained staff on the ...
(Date:2/6/2020)... ... February 06, 2020 , ... ... medical device and pharmaceutical trials, announced that Ms. Dorothy Abel has joined ... Dorothy oversees the development and execution of regulatory plans designed to help ...
Breaking Biology News(10 mins):
(Date:1/28/2020)... STATE COLLEGE, Pa. (PRWEB) , ... January 28, ... ... trusted line of Better Salivary Assay Kits . The new Salivary ... salivary bioscience research. “By measuring total immunoglobulin G in saliva, researchers can extend ...
(Date:1/24/2020)... ... January 24, 2020 , ... Sierra Instruments, ... flow meters and controllers ideal for BioPharm OEMS. Sierra also announces ... rotameters. These thermal instruments employ high-precision MEMS (Micro-Electro Mechanical Systems) technology utilizing an ...
(Date:1/22/2020)... ... January 21, 2020 , ... QCDx , a private biotech company ... blood draw, today announced the sale of the proprietary RareScope™ instrument to the Carole ... used in clinical cancer research. , “The RareScope can detect and isolate intact and ...
(Date:1/8/2020)... ... January 08, 2020 , ... RMA of ... and individuals grow their family, has announced that five of their Board-Certified reproductive ... Since 1991, the renowned publishing company Castle Connolly has compiled the ...
Breaking Biology Technology: